Congressmen highlight flaw in privacy rule
This article was originally published in Clinica
Executive Summary
Six House Democrats have objected to a "broad loophole" in the administration's proposed revisions to the medical privacy rule that would allow drug and medical device companies to get access to patient health records without patient permission.